Additional file 10. Â Diseases and biofunctions of lung cancers by ingenuity pathway analysis (IPA)
The correct understanding of tumour development relies on the comprehensive study of proteins. They ...
KRAS mutations in non-small cell lung cancer (NSCLC) are a predictor of resistance to EGFR-targeted ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...
Abstract Background Non-small cell lung carcinoma (NSCLC) remains the leading cause of cancer deaths...
Quantitative proteomic profiling the molecular signatures lung squamous carcinoma cell
Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures...
Advances in proteomic analysis of human samples are driving critical aspects of biomarker discovery ...
Histopathological classification of lung cancer has important implications in the application of cli...
IntroductionThe identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is...
Lung cancer is the leading cause of cancer death in men and women in Western nations, and is among t...
Lung cancer is one of the most common cancers worldwide, and is the top cause of cancer-related deat...
Lung cancer is the leading cause of preventable death globally and is broadly classified into adenoc...
Background: Because cell signaling and cell metabolic pathways are executed through proteins, protei...
Lung cancer is the leading cause of cancer death and non-small cell lung carcinoma (NSCLC) accountin...
Non-small cell lung cancer (NSCLC) cell lines are widely used model systems to study molecular aspec...
The correct understanding of tumour development relies on the comprehensive study of proteins. They ...
KRAS mutations in non-small cell lung cancer (NSCLC) are a predictor of resistance to EGFR-targeted ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...
Abstract Background Non-small cell lung carcinoma (NSCLC) remains the leading cause of cancer deaths...
Quantitative proteomic profiling the molecular signatures lung squamous carcinoma cell
Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures...
Advances in proteomic analysis of human samples are driving critical aspects of biomarker discovery ...
Histopathological classification of lung cancer has important implications in the application of cli...
IntroductionThe identification of key pathways dysregulated in non-small cell lung cancer (NSCLC) is...
Lung cancer is the leading cause of cancer death in men and women in Western nations, and is among t...
Lung cancer is one of the most common cancers worldwide, and is the top cause of cancer-related deat...
Lung cancer is the leading cause of preventable death globally and is broadly classified into adenoc...
Background: Because cell signaling and cell metabolic pathways are executed through proteins, protei...
Lung cancer is the leading cause of cancer death and non-small cell lung carcinoma (NSCLC) accountin...
Non-small cell lung cancer (NSCLC) cell lines are widely used model systems to study molecular aspec...
The correct understanding of tumour development relies on the comprehensive study of proteins. They ...
KRAS mutations in non-small cell lung cancer (NSCLC) are a predictor of resistance to EGFR-targeted ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...
DOI
Add to ORKG